Dr. Theresa M. Medina
Claim this profileUniversity of Colorado Hospital
Expert in Melanoma
Studies Skin Cancer
20 reported clinical trials
32 drugs studied
About Theresa M. Medina
Education:
- Obtained MD from the University of Colorado School of Medicine in 2015.
- Completed Residency in Internal Medicine at the University of Colorado Hospital in 2018.
- Finished Fellowship in Hematology/Oncology at the University of Colorado Hospital in 2021.
Experience:
- Currently serves as a Hematology and Oncology specialist at the University of Colorado Hospital.
Area of expertise
1Melanoma
Global LeaderStage IV
Stage III
BRAF positive
2Skin Cancer
Stage IV
BRAF positive
Stage III
Affiliated Hospitals
Clinical Trials Theresa M. Medina is currently running
RP1
for Advanced Skin Cancer in Transplant Patients
This trial tests RP1, a modified virus, in organ transplant recipients with advanced skin cancer. RP1 works by killing cancer cells and boosting the immune system to fight the cancer. The HIV-1 accessory protein Vpr has been shown to induce cell cycle arrest and kill tumor cells by apoptosis.
Recruiting1 award Phase 1 & 210 criteria
TSR-022
for Advanced Cancer
This trial is testing TSR-022, a new medicine that helps the immune system fight cancer by blocking a protein called TIM-3. TIM-3 has gained prominence as a potential candidate for cancer immunotherapy, where it has been shown that blocking TIM-3 with other treatments enhances the body's ability to fight tumors and suppress their growth. It targets patients with tumors, especially those who may not respond to standard treatments. The goal is to see if this medicine can help the immune system better attack cancer cells.
Recruiting1 award Phase 1
More about Theresa M. Medina
Clinical Trial Related6 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Theresa M. Medina has experience with
- Nivolumab
- Pembrolizumab
- Ipilimumab
- Avelumab
- TSR-022
- Relatlimab
Breakdown of trials Theresa M. Medina has run
Melanoma
Skin Cancer
Cancer
Merkel Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Theresa M. Medina specialize in?
Theresa M. Medina focuses on Melanoma and Skin Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Theresa M. Medina currently recruiting for clinical trials?
Yes, Theresa M. Medina is currently recruiting for 3 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Theresa M. Medina has studied deeply?
Yes, Theresa M. Medina has studied treatments such as Nivolumab, Pembrolizumab, Ipilimumab.
What is the best way to schedule an appointment with Theresa M. Medina?
Apply for one of the trials that Theresa M. Medina is conducting.
What is the office address of Theresa M. Medina?
The office of Theresa M. Medina is located at: University of Colorado Hospital, Aurora, Colorado 80045 United States. This is the address for their practice at the University of Colorado Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.